Groupe Hospitalier Universitaire CAREMEAU

Site:	Groupe Hospitalier Universitaire CAREMEAU
Address:
City:	Nimes
State:
Zip:
Country:	France

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	A Phase 3 Study to Evaluate Efficacy and Safety of Masitinib in Comparison to Imatinib in Patients With Gastro-Intestinal Stromal Tumour in First Line Medical Treatment	Terminated	Active	Masitinib, (AB1010)	NCT00812240